Jesus Alejandro Gabutti MD, Presenter: Nothing to Disclose

Ailan Hitandhui Barrientos-Priego MD, Abstract Co-Author: Nothing to Disclose

Joaquin Nunez Gomez MD, Abstract Co-Author: Nothing to Disclose

Daniela Canaviri MD, Abstract Co-Author: Nothing to Disclose

Fritz Hofmann MD, Abstract Co-Author: Nothing to Disclose

Jorge Vazquez-Lamadrid MD, Abstract Co-Author: Nothing to Disclose

Fernando Cano MD, Abstract Co-Author: Nothing to Disclose

To explain the pathophysiology con oncogenic osteomalacia. To explain the importance of molecular imaging, with special emphasis in SPECT-CT for the correct diagnosis. To show and explain the main imaging findings in MRI, US, CT and plain films of mesenchymal tumor, systemic manifestations, complications and consequences of a delay diagnosis. To emphasize the importance of the radiologist in the approach of a patient of suspected oncogenic osteomalacia.

Introduction: epidemiology and pathogenesis. Clinical and laboratory findings. Imaging work-up, indications and algorithm. SPECT and SPECT-CT findings, radiotracers and technique. Other molecular imaging methods. Review of cases with radiologic-pathologic correlation: MRI and ultrasound appearance of the mesenchymal tumor. CT and plain films of the systemic manifestations and complications. Summary of the teaching points and conclusion.

http://abstract.rsna.org/uploads/2014/14003762/14003762_wxze.pdf

Gabutti, J, Barrientos-Priego, A, Nunez Gomez, J, Canaviri, D, Hofmann, F, Vazquez-Lamadrid, J, Cano, F, Oncogenic Osteomalacia, What Does It Look Like? From SPECT to Plain Films with Pathologic Correlation.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003762.html